State-Targeting Stabilization of Adenosine A


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Nov 2021
Historique:
received: 24 09 2021
revised: 19 11 2021
accepted: 23 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 27 1 2022
Statut: epublish

Résumé

G-protein coupled receptors (GPCRs) are known for their low stability and large conformational changes upon transitions between multiple states. A widely used method for stabilizing these receptors is to make chimeric receptors by fusing soluble proteins (i.e., fusion partner proteins) into the intracellular loop 3 (ICL3) connecting the transmembrane helices 5 and 6 (TM5 and TM6). However, this fusion approach requires experimental trial and error to identify appropriate soluble proteins, residue positions, and linker lengths for making the fusion. Moreover, this approach has not provided state-targeting stabilization of GPCRs. Here, to rationally stabilize a class A GPCR, adenosine A

Identifiants

pubmed: 34884716
pii: ijms222312906
doi: 10.3390/ijms222312906
pmc: PMC8657880
pii:
doi:

Substances chimiques

Adenosine A2 Receptor Agonists 0
Ligands 0
Proteins 0
Receptor, Adenosine A2A 0
Recombinant Fusion Proteins 0
Adenosine K72T3FS567

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 18H05420
Organisme : Japan Society for the Promotion of Science
ID : 18H05425

Références

Exp Mol Med. 2016 Feb 05;48:e207
pubmed: 26846450
F1000Res. 2016 Feb 18;5:189
pubmed: 26973785
Science. 2007 Nov 23;318(5854):1266-73
pubmed: 17962519
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13936-41
pubmed: 17709746
PLoS One. 2011;6(8):e24109
pubmed: 21909381
Anal Biochem. 2018 May 1;548:7-14
pubmed: 29432751
Nat Chem Biol. 2015 Mar;11(3):221-8
pubmed: 25664692
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10744-9
pubmed: 18664584
Structure. 2011 Sep 7;19(9):1283-93
pubmed: 21885291
Nature. 2012 Jan 29;482(7384):237-40
pubmed: 22286059
Elife. 2018 Jun 21;7:
pubmed: 29927385
Nature. 2016 Sep 14;537(7620):320-7
pubmed: 27629638
Cell. 2021 Apr 1;184(7):1884-1894.e14
pubmed: 33743210
Microb Cell Fact. 2012 Jun 13;11:78
pubmed: 22694812
Nature. 2015 Mar 12;519(7542):247-50
pubmed: 25533960
Signal Transduct Target Ther. 2021 Jan 8;6(1):7
pubmed: 33414387
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14808-13
pubmed: 18812512
Science. 2012 Jul 13;337(6091):232-6
pubmed: 22798613
Protein Sci. 2010 Oct;19(10):1991-5
pubmed: 20665689
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13284-9
pubmed: 22847407
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):E5478-85
pubmed: 26396255
Biophys J. 2000 Nov;79(5):2754-60
pubmed: 11053148
Structure. 2012 Jun 6;20(6):967-76
pubmed: 22681902
J Chem Theory Comput. 2015 Feb 10;11(2):609-22
pubmed: 25866491
Biophys Physicobiol. 2019 Nov 29;16:304-309
pubmed: 31984185
Science. 2013 Sep 20;341(6152):1387-90
pubmed: 24030490
Science. 2008 Nov 21;322(5905):1211-7
pubmed: 18832607
Nature. 2016 May 04;533(7602):265-8
pubmed: 27144352
Nature. 2016 Aug 4;536(7614):104-7
pubmed: 27462812
J Mol Biol. 2002 Oct 18;323(2):253-62
pubmed: 12381319
Science. 2007 Nov 23;318(5854):1258-65
pubmed: 17962520
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):877-82
pubmed: 18192400
Bioinformatics. 2017 Sep 1;33(17):2765-2767
pubmed: 28481970
Proteins. 2006 Nov 15;65(3):712-25
pubmed: 16981200
Physiol Rev. 2018 Jul 1;98(3):1591-1625
pubmed: 29848236
Nucleic Acids Res. 2012 Jan;40(Database issue):D370-6
pubmed: 21890895
Nature. 2012 Nov 8;491(7423):222-7
pubmed: 23135467
Nature. 2011 May 18;474(7352):521-5
pubmed: 21593763
Nat Rev Drug Discov. 2008 Apr;7(4):339-57
pubmed: 18382464
Annu Rev Biochem. 2018 Jun 20;87:897-919
pubmed: 29925258
Science. 2003 Nov 21;302(5649):1364-8
pubmed: 14631033

Auteurs

Masaya Mitsumoto (M)

Department of Structural Molecular Science, School of Physical Sciences, SOKENDAI, The Graduate University for Advanced Studies, Shonan Village, Hayama 240-0193, Kanagawa, Japan.
Research Center of Integrative Molecular Systems, Institute for Molecular Science (IMS), National Institutes of Natural Sciences (NINS), Okazaki 444-8585, Aichi, Japan.

Kanna Sugaya (K)

Department of Chemistry, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.

Kazuki Kazama (K)

Department of Chemistry, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.

Ryosuke Nakano (R)

Department of Chemistry, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.

Takahiro Kosugi (T)

Department of Structural Molecular Science, School of Physical Sciences, SOKENDAI, The Graduate University for Advanced Studies, Shonan Village, Hayama 240-0193, Kanagawa, Japan.
Research Center of Integrative Molecular Systems, Institute for Molecular Science (IMS), National Institutes of Natural Sciences (NINS), Okazaki 444-8585, Aichi, Japan.
Protein Design Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences (NINS), Okazaki 444-8585, Aichi, Japan.

Takeshi Murata (T)

Department of Chemistry, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.
Membrane Protein Research Center, Chiba University, Chiba 263-8522, Japan.

Nobuyasu Koga (N)

Department of Structural Molecular Science, School of Physical Sciences, SOKENDAI, The Graduate University for Advanced Studies, Shonan Village, Hayama 240-0193, Kanagawa, Japan.
Research Center of Integrative Molecular Systems, Institute for Molecular Science (IMS), National Institutes of Natural Sciences (NINS), Okazaki 444-8585, Aichi, Japan.
Protein Design Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences (NINS), Okazaki 444-8585, Aichi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH